Eli Lilly 2012 Annual Report Download - page 101

Download and view the complete annual report

Please find page 101 of the 2012 Eli Lilly annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 164

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140
  • 141
  • 142
  • 143
  • 144
  • 145
  • 146
  • 147
  • 148
  • 149
  • 150
  • 151
  • 152
  • 153
  • 154
  • 155
  • 156
  • 157
  • 158
  • 159
  • 160
  • 161
  • 162
  • 163
  • 164

89
(a)2. Financial Statement Schedules
The consolidated financial statement schedules of the company and its subsidiaries have been omitted
because they are not required, are inapplicable, or are adequately explained in the financial statements.
Financial statements of interests of 50 percent or less, which are accounted for by the equity method, have
been omitted because they do not, considered in the aggregate as a single subsidiary, constitute a significant
subsidiary.
(a)3. Exhibits
3.1 Amended Articles of Incorporation
3.2 By-laws, as amended
4.1 Form of Indenture with respect to Debt Securities dated as of February 1, 1991, between Eli Lilly
and Company and Citibank, N.A., as Trustee
4.2 Agreement dated September 13, 2007 appointing Deutsche Bank Trust Company Americas as
Successor Trustee under the Indenture listed above
4.3 Form of Standard Multiple-Series Indenture Provisions dated, and filed with the Securities and
Exchange Commission on February 1, 1991
4.4 Form of Fiscal Agency Agreement dated May 30, 2001, between Eli Lilly and Company and Citibank,
N.A., Fiscal Agent, relating to Resetable Floating Rate Debt Security due 20371
4.5 Form of Resetable Floating Rate Debt Security due 20371
10.1 2002 Lilly Stock Plan, as amended2
10.2 Form of two-year Performance Award under the 2002 Lilly Stock Plan2
10.3 Form of Shareholder Value Award under the 2002 Lilly Stock Plan2
10.4 Form of Restricted Stock Unit under the 2002 Lilly Stock Plan2
10.5 The Lilly Deferred Compensation Plan, as amended2
10.6 The Lilly Directors’ Deferral Plan, as amended2
10.7 The Eli Lilly and Company Bonus Plan, as amended2
10.8 The Eli Lilly and Company Executive Officer Incentive Plan2
10.9 2007 Change in Control Severance Pay Plan for Select Employees, as amended effective
October 20, 20102
10.10 2007 Change in Control Severance Pay Plan for Select Employees, as amended effective October
18, 20122
10.11 Arrangement regarding retirement benefits for Robert A. Armitage2
10.12 Arrangement regarding severance for Dr. Jan Lundberg2
10.13 Guilty Plea Agreement in The United States District Court for the Eastern District of Pennsylvania,
United States of America v. Eli Lilly and Company
10.14
Settlement Agreement among the company and the United States of America, acting through the
United States Department of Justice, Civil Division, and the United States Attorney’s Office of the
Eastern District of Pennsylvania, the Office of the Inspector General of the Department of Health
and Human Services, TRICARE Management Activity, and the United States Office of Personnel
Management, and certain individual relators
10.15 Corporate Integrity Agreement between the company and the Office of Inspector General of the
Department of Health and Human Services
12 Statement re: Computation of Ratio of Earnings (Loss) to Fixed Charges